Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)
SMI Mahboubi Rabbani, A Zarghi - Expert opinion on therapeutic …, 2019 - Taylor & Francis
Introduction: COX-2 is a key enzyme in the process of prostaglandins (PGs) synthesis. The
products of this enzyme could play a major role as the mediators of the inflammatory …
products of this enzyme could play a major role as the mediators of the inflammatory …
Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018).
MR SMI, A Zarghi - Expert Opinion on Therapeutic Patents, 2019 - europepmc.org
COX-2 is a key enzyme in the process of prostaglandins (PGs) synthesis. The products of
this enzyme could play a major role as the mediators of the inflammatory response and …
this enzyme could play a major role as the mediators of the inflammatory response and …
[PDF][PDF] Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)
SMIM Rabbani, A Zarghi - EXPERT OPINION ON THERAPEUTIC …, 2019 - researchgate.net
Introduction: COX-2 is a key enzyme in the process of prostaglandins (PGs) synthesis. The
products of this enzyme could play a major role as the mediators of the inflammatory …
products of this enzyme could play a major role as the mediators of the inflammatory …
Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)
SMIM Rabbani, A Zarghi - Expert opinion on therapeutic …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction COX-2 is a key enzyme in the process of prostaglandins (PGs) synthesis. The
products of this enzyme could play a major role as the mediators of the inflammatory …
products of this enzyme could play a major role as the mediators of the inflammatory …